Supply of Rabies Vaccine (Human use)

The STATE PHARMACEUTICALS CORPORATION OF SRI LANKA in Sri Lanka from Asia region had released this tender for Tenders are invited for Supply of 700,000 Doses of Rabies Vaccine (Human use) 0.5ml/1ml-Inactivated Rabies Vaccine (Human use) (0.5ml/1ml). Each dose 0.1ml to contain at least 7 IU/ml of Rabies antigen as an inactivated freeze-dried powder form. Each vial should be either 0.5ml or 1ml. The Vaccine should be suitable for human use, produced in cell culture. (eg. Primary chickembryo cell culture Rabies Vaccine, Vero Cell rabies Vaccine) The vaccine should comply with the Rabies Vaccine as the Pharmacopoeial requirement of vaccine and biological products. Note: 1.Cold chain monitors or WHO recommended other cold chain monitoring device should be included for each cartoon and the cold chain should be maintained according to the manufacturer's instructions during storage, transport & delivery of vaccine. 2.The following documents should be submitted pre- shipment for each lot of vaccine dispatched. (a). Invoice (b).Certificate of origin (c). Certificate of analysis. (d). Lot release certificate from National control Laboratory (NCL) from country of origin. (e). Summary lot protocols of production procedure & quality control testing. (f). Packing list. (g). Copy of product information leaflet (PIL). These documents should be submitted pre-shipment to the National Control Laboratory for Vaccines (MRI) Sri Lanka. 3.Airway bill & temperature monitoring data should be submitted with the sample submission for lot release to NCL. 4.The product should be only from fresh stocks and should have a minimum of 2/3 of remaining shelf life at the time of delivery at MSD. 5.The vaccine should be stored at a temperature range of 2'C - 8'C & should not be frozen. 6.Each vial should be labelled accordingly indicating both date of manufacture and expiry. 700,000 Doses 700,000 Doses/ August 2024 7.The vaccine should be recommended by WHO for intradermal use / the vaccine should be recommended and registered by the National Regulatory Authority of the manufacturing country or a reference country for intradermal use. 8. For the procurement purpose, single dose will be considered as 0.1ml 9.Each vial should be provided with a suitable sterile diluent (5 vials of vaccine + 5 vial of diluent to be packed in the same box). 10. Immunization record cards should be provided for each vial. Patient information should be provided in Sinhala language for 75% of the consignment and Tamil language for the remain 25% (Template to be obtain from MRI). 11. Director/MSD should be informed two weeks prior to the arrival of vaccine. qty 700,000 doses The amount of Bid Bond: LKR 5,426,540.00 or USD 17,677.00. Bid Bond should be submitted with valid up to 25.03.2024 together with the bid Bid should be valid till 24.02.2024. Nonrefundable Bid Fee Rs. 60,000.00 + Taxes. Bid Evaluation Summary sheets should be submitted with the Bid (Please refer SPC website for more details) Tender Type: DHS Status: Open Closing Date: 29-08-2023 11:00 am Nonrefundable Bid Fee: Rs. 60,000/= + Taxes with tender notice no. DHS/P/M/WW/04/24 published on 19 Jul 2023. The tender expired on 29 Aug 2023. This tender is sourced from Official Website and is eligible for suppliers interested in Vaccines. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 3346490.